Oncology

IMATINIB MESYALATE

  • Brand NameVeltero
  • Strength3.5 mg
  • Dosage typeInjection
  • therapeutic areaOncology

INDICATION

It is a proteasome inhibitor indicated for:

  • Treatment of adult patients with multiple myeloma
  • Treatment of adult patients with mantle cell lymphoma